Clinical Trial Update: Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 safety study of liver transplantation for hilar cholangiocarcinoma; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hilar Cholangiocarcinoma

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Hilar Cholangiocarcinoma | Phase 1, Phase 2 | Status: UNKNOWN